Published February 14, 2025
| Version v1
Journal article
Open
The Impact of Polycystic Ovary Syndrome (PCOS) on Metabolic and Cardiovascular Health
Authors/Creators
- 1. Assistant of the Department of Obstetrics and Gynecology No.3
- 2. 1st year clinical resident
Description
Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age. Characterized by hormonal imbalances, irregular ovulation, and metabolic disturbances, PCOS is not only a reproductive disorder but also a significant risk factor for cardiovascular disease (CVD) and type 2 diabetes. This article examines the metabolic consequences of PCOS, including insulin resistance, dyslipidemia, obesity, and hypertension, and discusses current and emerging therapeutic strategies.
Files
358-359 Kamarova I.pdf
Files
(397.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:0ad3bd47a22594acf42d9d18023622cd
|
397.3 kB | Preview Download |
Additional details
References
- 1. Azziz, R., Carmina, E., Chen, Z., et al. (2016). "Polycystic ovary syndrome." Nature Reviews Disease Primers, 2, 16057.
- 2. Escobar-Morreale, H. F. (2018). "Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment." Nature Reviews Endocrinology, 14(5), 270-284.
- 3. Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010). "Impaired glucose tolerance, type 2 diabetes and metabolic risk in PCOS: A systematic review and meta-analysis." Human Reproduction Update, 16(4), 347-363.